June 11, 2013 in Russia was opened laboratory and production complex "TSGRM HSCI" (Center for Genetics and Regenerative Medicine Institute of Human Stem Cells).
Creating such a complex is a strategic step for the whole industry.The main purpose of the laboratory-industrial complex biomedical produce cell products, and drugs of foreign developers.Thanks to what will be available and effective pre-clinical and clinical trials of cell preparations, independent production of cell products and their introduction for use in medicine for therapeutic purposes.
Laboratory and Production Complex "TSGRM HSCI" was designed in 2011, and that same year began its construction.The complex was built in just 15 months.Construction is financed HSCI itself from its own funds and partly Sberbank of Russia.If we talk about the amount of investment, the minimum size it was 10 million dollars.
Design and construction of the complex took place in accordance with GMP standards (Good Manufacturing Practice).The complex consist
June 11, 2013 during the opening of the complex red tape cut Isaev Arthur - Director of HSCI and special guests: Commissioners Alex G. - Head of the Department of Science, Industrial Policy and Entrepreneurship of Moscow and the Margolit Gennady - Executive Director of the Market for Innovations and Investments of the Moscow Stock Exchange.
As Artur Isayev says, created the new complex will be the so-called Center for prototyping, which will provide services for the development, production and introduction of new cell products and technologies on a contract basis.The new facility has a production capacity, which will further develop the previously developed and registered HSCI products and services in the field of regeneration and genetics.
official part of the ceremony moved to acquaint visitors with the part of the laboratory and production complex.
guests visited the Laboratory of Molecular Genetics, which is intended for the diagnosis of hereditary diseases (including using a DNA chip Entogen) and providing all kinds of services for IVF clinics Russia for preimplantation genetic diagnosis.
was further examined by a laboratory cell cultures, which are developed and produced tissue-engineered products, and will provide services based on cellular technology.Will be held SPRS / SPRG-therapy on the skin restoration, soft periodontal tissues, as well as the creation of transplants.
Created pharmaceutical unit, which will be developed, produced and monitored cell preparations.
Guests also saw unit of umbilical cord blood stem cells.There will be a repository of newborn blood taken from the umbilical cord.
The clinic provides Reprobank - Bank reproductive tissues.There will be the collection of human reproductive cells and performed genetic testing to identify hereditary diseases.
The new laboratory and production complex until 2017 it is planned to develop 10-20 new products and services of cellular regenerative and genetic medicine.